Idursulfase
Top View
- Clinical Trials, Progression-Speed Differentiating Features, and Swiftness Rule of the Innovative Targets of First-In-Class Drugs
- Specialty Drug List 10-24-11
- May2013 CPG Updates
- Specialty Medications That Unitypoint at Home Specialty Pharmacy Can Provide Or Facilitate Access to and Is Subject to Change
- 1986 Senior Staff Fellow, Human Genetics Branch National Institute of Child Health and Human Developmental Bethesda, MD
- Lysosomal Storage Disorders
- Availability, Accessibility and Delivery to Patients of the 28 Orphan
- Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline
- CDER List of Licensed Biological Products With
- Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
- NCL Red List at All NCL Trusts Except RNOH, Who Can Share Prescribing with a GP Within the Context of Their MDT OPAT Service
- Medical Policy Statement
- Idursulfase 1 .Pub
- China Rare Disease Market: Large and Untapped Opportunity
- For Peer Review Only - Page 1 of 59 BMJ Open
- Essential List of Medicinal Products for Rare Diseases: Recommendations from the Irdirc Rare Disease Treatment Access Working Group William A
- Biochemical Genetics
- An Overview of the Orphan Medicines Market in Turkey Güvenç Koçkaya, MD, Msc1,*, Albert I